Literature DB >> 2762698

Vaccine delivery management.

J Cheyne1.   

Abstract

During the typical 12- to 18-month voyage of a vaccine from manufacturer to immunization site, many situations arise in which the cold chain may be interrupted. Extensive efforts have been made in the 1980s to ensure an uninterrupted cold chain through the use of improved equipment and better training of personnel. One important advance is the vaccine cold-chain monitor, which identifies weak spots in the cold chain and prevents the use of heat-damaged vaccine. Further improvements will require efforts by the recipient countries (e.g., better use of the private sector for transport and equipment management), by donor agencies (e.g., greater consideration of the operational and maintenance costs of the equipment selected and resolution of fuel shortages), and by industry (e.g., more appropriate packaging and pricing of vaccine, extension of the expiration period, and increased heat stability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762698     DOI: 10.1093/clinids/11.supplement_3.s617

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

1.  Stabilization of vaccines and antibiotics in silk and eliminating the cold chain.

Authors:  Jeney Zhang; Eleanor Pritchard; Xiao Hu; Thomas Valentin; Bruce Panilaitis; Fiorenzo G Omenetto; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

2.  Interactive learning and action: realizing the promise of synthetic biology for global health.

Authors:  A Wieke Betten; Anneloes Roelofsen; Jacqueline E W Broerse
Journal:  Syst Synth Biol       Date:  2013-07-27

3.  A cross-sectional study on vaccine coverage and seroprevalence in schoolchildren in Andorra.

Authors:  E Portella; J Goicoechea; J Penella
Journal:  Soz Praventivmed       Date:  1993

4.  Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.

Authors:  Dominique N Price; Nitesh K Kunda; Rajaun Ellis; Pavan Muttil
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.580

Review 5.  Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis.

Authors:  David E Phillips; Joseph L Dieleman; Stephen S Lim; Jessica Shearer
Journal:  BMC Health Serv Res       Date:  2017-09-26       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.